JP7343089B2 - 保存増強剤 - Google Patents
保存増強剤 Download PDFInfo
- Publication number
- JP7343089B2 JP7343089B2 JP2018228036A JP2018228036A JP7343089B2 JP 7343089 B2 JP7343089 B2 JP 7343089B2 JP 2018228036 A JP2018228036 A JP 2018228036A JP 2018228036 A JP2018228036 A JP 2018228036A JP 7343089 B2 JP7343089 B2 JP 7343089B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- erythrulose
- phytantriol
- composition
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
[先行技術文献]
[特許文献]
[特許文献2]欧州特許出願公開第A-1161938号明細書
[非特許文献]
[非特許文献2]A.Domsch,“Cosmetic Compositions”,Verlag fuer chemische Industrie(ed.H.Ziolkowsky),4th edition,1992
[非特許文献3]the International Cosmetic Ingredient Dictionary&Handbook
[非特許文献4]“Handbook of Water soluble gums and resins” by Robert L.Davidson(Mc Graw Hill Book Company(1980))
抗微生物有効性は、規制による曝露試験方法(NF EN ISO11930)と同様に評価する。そのため、それぞれの活性物質のエタノール溶液を調製し、滅菌条件下において、0.85重量%NaClを含む生理学的血清に、表1に概説された濃度でさらに溶解させる。フィタントリオールを含む試料を、10重量%エタノールを補った生理学的血清に可溶化させ、エリトルロースのみを含む試料を、1重量%エタノールを補った生理学的血清に可溶化させた。
さらなる実施形態は以下のとおりである。
[実施形態1]
フィタントリオール及びエリトルロースを含む局所組成物。
[実施形態2]
フィタントリオールの量は、前記組成物の総重量に基づいて約0.01~2.9重量%の範囲、より好ましくは約0.01~2.5重量%の範囲、最も好ましくは0.05~2.0重量%の範囲で選択される量である、実施形態1に記載の局所組成物。
[実施形態3]
エリトルロースの量は、前記組成物の総重量に基づいて約0.005~2重量%の範囲、より好ましくは約0.01~1重量%の範囲、最も好ましくは0.025~0.5重量%の範囲で選択される量である、実施形態1に記載の局所組成物。
[実施形態4]
前記局所組成物の総重量に基づいて、エリトルロースの量は、0.05~0.2重量%の範囲で選択され、フィタントリオールの量は、0.1~2重量%の範囲で選択される、実施形態1に記載の局所組成物。
[実施形態5]
化粧組成物又は医薬組成物である、実施形態1~4のいずれか1つに記載の局所組成物。
[実施形態6]
O/Wエマルション、W/Oエマルション、ゲル、シャンプー調製物又はヘアコンディショナーである、実施形態5に記載の局所組成物。
[実施形態7]
健康な皮膚恒常性を維持するため、且つ/又は皮膚マイクロバイオームバランスを維持するための、実施形態1~5のいずれか1つに記載の局所組成物の使用。
[実施形態8]
保存増強剤としての、フィタントリオールとエリトルロースとの組み合わせの使用。
[実施形態9]
好ましくは大腸菌(E.coli)に対する抗微生物剤としての、フィタントリオールとエリトルロースとの組み合わせの使用。
[実施形態10]
皮膚及び/又は頭皮を治療する方法であって、前記皮膚及び/又は頭皮を実施形態1~5のいずれか1つに記載の局所組成物と接触させる工程を含む方法。
[実施形態11]
健康な皮膚恒常性を維持するため、且つ/又は皮膚マイクロバイオームバランスを維持するための、実施形態10に記載の方法。
[実施形態12]
前記健康な皮膚恒常性及び/又は皮膚マイクロバイオームバランスは、それを必要とする人の皮膚上の大腸菌(E.coli)の集団を減少させることによって維持される、実施形態11に記載の方法。
[実施形態13]
大腸菌(E.coli)を死滅させ、且つ/又は阻害する方法であって、大腸菌(E.coli)をフィタントリオールとエリトルロースとの組み合わせと接触させることを含む方法。
Claims (7)
- 大腸菌(E.coli)過多に対する処理を必要とする人における、健康な皮膚恒常性を維持するため、且つ/又は皮膚マイクロバイオームバランスを維持するための局所組成物であって、フィタントリオール及びエリトルロースを含む局所組成物。
- フィタントリオールの量は、前記組成物の総重量に基づいて0.01~2.9重量%の範囲で選択される量である、請求項1に記載の局所組成物。
- エリトルロースの量は、前記組成物の総重量に基づいて0.005~2重量%の範囲で選択される量である、請求項1に記載の局所組成物。
- 前記局所組成物の総重量に基づいて、エリトルロースの量は、0.05~0.2重量%の範囲で選択され、フィタントリオールの量は、0.1~2重量%の範囲で選択される、請求項1に記載の局所組成物。
- 化粧組成物又は医薬組成物である、請求項1~4のいずれか一項に記載の局所組成物。
- O/Wエマルション、W/Oエマルション、ゲル、シャンプー調製物又はヘアコンディショナーである、請求項5に記載の局所組成物。
- 局所組成物を大腸菌(E.coli)による汚染から保護するための保存増強剤としての、フィタントリオールとエリトルロースとの組み合わせの使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17205658.2 | 2017-12-06 | ||
EP17205658.2A EP3494958B1 (en) | 2017-12-06 | 2017-12-06 | Preservation booster |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2019108325A JP2019108325A (ja) | 2019-07-04 |
JP2019108325A5 JP2019108325A5 (ja) | 2021-10-07 |
JP7343089B2 true JP7343089B2 (ja) | 2023-09-12 |
Family
ID=60582521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018228036A Active JP7343089B2 (ja) | 2017-12-06 | 2018-12-05 | 保存増強剤 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10933002B2 (ja) |
EP (1) | EP3494958B1 (ja) |
JP (1) | JP7343089B2 (ja) |
KR (1) | KR102698105B1 (ja) |
CN (1) | CN109875906B (ja) |
ES (1) | ES2822349T3 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112020000120B1 (pt) * | 2017-07-06 | 2023-03-28 | Dsm Ip Assets B.V | Uso de eritrulose, método de prevenir decaimento e decomposição microbianos, composição cosmética ou farmacêutica para aplicação tópica e processo para a preparação de uma composição |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050131077A1 (en) | 2003-11-07 | 2005-06-16 | L'oreal | Preventing or reducing the adhesion of microorganisms with phytanetriol |
JP2012500195A (ja) | 2008-08-15 | 2012-01-05 | エクストリウム ラボラトーリーズ, インコーポレーテッド | 穏やかな、非刺激性、非アルコール性皮膚消毒剤 |
US20120128602A1 (en) | 2010-11-19 | 2012-05-24 | Kao Corporation | Skin compositions containing low levels of colorants |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0221728B1 (en) * | 1985-10-22 | 1992-07-15 | Anthony N. Silvetti, Sr. | Monosaccharide containing wound healing preparation |
AU4647300A (en) | 1999-04-19 | 2000-11-02 | Procter & Gamble Company, The | Skin care compositions containing combination of skin care actives |
FR2809954B1 (fr) | 2000-06-08 | 2004-03-12 | Oreal | Utilisation du phytantriol comme agent anti-pollution, notamment dans une composition cosmetique |
EP1407757A1 (en) * | 2002-10-09 | 2004-04-14 | Ciba SC Holding AG | Preparation of micronised UV absorbers |
FR2861989B1 (fr) * | 2003-11-07 | 2005-12-30 | Oreal | Utilisation cosmetique du phytantriol comme agent empechant ou reduisant l'adhesion des microorganismes sur la surface de la peau et/ou des muqueuses |
FR2927801B1 (fr) * | 2008-02-22 | 2010-03-05 | Sederma Sa | Composition cosmetique hydratante comprenant une combinaison d'homarine et d'erythritol |
USRE46698E1 (en) * | 2011-12-21 | 2018-02-06 | Merck Patent Gmbh | Use of cyclohexanol derivatives as antimicrobial active compounds |
US20150118165A1 (en) * | 2012-05-08 | 2015-04-30 | Merck Patent Gmbh | Use of cyclohexanol ethers having antimicrobial properties |
WO2012143576A2 (en) * | 2012-08-23 | 2012-10-26 | Symrise Ag | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) |
-
2017
- 2017-12-06 EP EP17205658.2A patent/EP3494958B1/en active Active
- 2017-12-06 ES ES17205658T patent/ES2822349T3/es active Active
-
2018
- 2018-12-04 US US16/208,616 patent/US10933002B2/en active Active
- 2018-12-05 KR KR1020180154864A patent/KR102698105B1/ko active IP Right Grant
- 2018-12-05 JP JP2018228036A patent/JP7343089B2/ja active Active
- 2018-12-06 CN CN201811485532.3A patent/CN109875906B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050131077A1 (en) | 2003-11-07 | 2005-06-16 | L'oreal | Preventing or reducing the adhesion of microorganisms with phytanetriol |
JP2012500195A (ja) | 2008-08-15 | 2012-01-05 | エクストリウム ラボラトーリーズ, インコーポレーテッド | 穏やかな、非刺激性、非アルコール性皮膚消毒剤 |
US20120128602A1 (en) | 2010-11-19 | 2012-05-24 | Kao Corporation | Skin compositions containing low levels of colorants |
Also Published As
Publication number | Publication date |
---|---|
EP3494958B1 (en) | 2020-07-29 |
CN109875906B (zh) | 2023-03-31 |
CN109875906A (zh) | 2019-06-14 |
KR102698105B1 (ko) | 2024-08-23 |
US20190167549A1 (en) | 2019-06-06 |
US10933002B2 (en) | 2021-03-02 |
BR102018075165A2 (pt) | 2019-06-25 |
EP3494958A1 (en) | 2019-06-12 |
ES2822349T3 (es) | 2021-04-30 |
JP2019108325A (ja) | 2019-07-04 |
KR20190067102A (ko) | 2019-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7286907B2 (ja) | 局所用組成物 | |
ES2937308T3 (es) | Dispositivo de detección de radiación, dispositivo de adquisición de imágenes de radiación y método de adquisición de imágenes de radiación | |
JP7343089B2 (ja) | 保存増強剤 | |
JP7187740B2 (ja) | 新規の使用 | |
JP7114847B2 (ja) | 新規な使用 | |
CN110831564B (zh) | 局部用组合物 | |
BR102018075165B1 (pt) | Composição tópica e seu uso, uso de uma combinação de fitantriol e eritrulose e método cosmético para tratar a pele e/ou o couro cabeludo | |
ES2657599T3 (es) | Nuevas composiciones que comprenden p-hidroxibencilaminas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210830 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210830 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220802 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20221025 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221219 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230131 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230428 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230801 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230816 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7343089 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |